Intensity Therapeutics Inc

NASDAQ:INTS

3.68

+0.01 (+0.27%)

4:03:34 PM EDT: $3.68 0.00 (0.00%)

Intensity Therapeutics Inc Stock, NASDAQ:INTS

61 Wilton Road, 3rd floor, Westport, Connecticut 06880

United States of America

Phone: +1.203.221.7381

Number of Employees: 16

http://www.intensitytherapeutics.com

Description

Intensity Therapeutics, Inc. engages in the operation a biotechnology company which develops novel immune-based therapeutic products for cancer treatment. Its product INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Westport, CT.